La Jolla Institute scientist identifies pivotal cellular protein underlying eczema
SAN DIEGO – January 9, 2014 Researchers from the La Jolla Institute for Immunology have revealed a critical player in
SAN DIEGO – January 9, 2014 Researchers from the La Jolla Institute for Immunology have revealed a critical player in
The new members are: Sergio Jinich, a distinguished real estate and construction executive in the U.S. and Mexico; Tina Nova,
Type 1 diabetes is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables one
SAN DIEGO – June 17, 2014 Research toward the world’s first vaccine for heart disease continues to advance at the
SAN DIEGO – July 8, 2014 In a study published yesterday in the scientific journal Nature Immunology, a group at
LA JOLLA, CA— Dr. Mitchell Kronenberg, President and Chief Scientific of Officer of the La Jolla Institute for Immunology has
LA JOLLA, CA—Multiple sclerosis, a debilitating neurological disease, is triggered by self-reactive T cells that successfully infiltrate the brain and
LA JOLLA, CA— One goal of immunotherapy is to rally a patient’s often over‐burdened immune cells to effectively attack a
LA JOLLA, CA—Pandurangan Vijayanand (Vijay), M.D., Ph.D., has been appointed to the position of associate professor in the Division of
LA JOLLA, CA—The La Jolla Institute for Immunology (LJI) is pleased to announce that visionary business leader Richard S. Bodman
LA JOLLA, CA—Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong
LA JOLLA, CA—The La Jolla Institute for Immunology is pleased to announce that Larry Spitcaufsky and Hunt Pettit have been